What are the top concerns when choosing a clinical trial site in developed or emerging markets, and do cheaper prices in emerging markets outweigh those concerns?
Dan Casey has been appointed vice president business development, and Dale A. Dyer was named director of business development at Norwich Pharmaceuticals.
Norwich Pharmaceuticals, Inc. is expanding its development services offerings through a selective buildup of technical personnel and capital investments in specialized equipment.